v3.26.1
OPTIONS, RESTRICTED STOCK UNITS AND WARRANTS (Tables)
 6 Months Ended
Jun. 30, 2026
Accumulated Other Comprehensive Income (Loss) [Line Items]  
SCHEDULE OF EXERCISE PRICE OF STOCK OPTIONS

The following table presents information related to stock options as of June 30, 2026:

 

  

Options Outstanding  Options Exercisable 
Exercise  Number of  

Weighted Average

Remaining Life

  

Exercisable

Number of

 
Price  Options   In Years   Options 
$ Under 9.99    2,900,000    8.4    2,900,000 
$ 10.00-19.99    15,000    6.9    15,000 
$ 20.00-49.99    3,000    2.7    3,000 
$ 50.00-69.99    3,000    3.5    3,000 
       2,921,000    8.4    2,921,000 
SCHEDULE OF OPTIONS GRANTED ASSUMPTIONS USING BLACK-SCHOLES OPTION

The fair value of options granted during the six months ended June 30, 2026 was estimated using the Black-Scholes option pricing model with the following assumptions:

 

Assumption  Value 
Weighted average grant date fair value  $3.08 
Expected volatility   124.22%
Risk-free interest rate   4.15%
Expected dividend yield   0%
Expected Term (in years)   10 
SCHEDULE OF INFORMATION RELATED TO WARRANTS

The following table summarizes information with respect to outstanding warrants to purchase common stock of Streamex Corp. as of June 30, 2026:

  

Exercise Price   Number of Warrants   Expiration Date
$0.3000    11,982   Nov-29
 0.9547    577,916   Sep-28
 3.3640    117,828   Jul-29
 4.0660    25,000   Nov-32
 4.4550    107,483   Jun-28
 4.6626    5,580   Apr-29
 4.9252    49,550   Mar-29
 4.9290    71,593   Mar-29
 5.1358    99,243   Jul-28
 7.1810    83,270   Jul-28
 7.5020    9,846   Jul-28
 7.9630    21,369   Aug-28
 9.0000    21,709   Jun-27
 9.5960    84,390   Jan-29
 10.0992    19,118   Aug-28
 10.2600    51,705   Sep-28
 10.4678    84,296   Sep-28
 11.3000    40,417   Oct-28
 13.2800    96,198   Nov-28
 48.0000    12,500   Jul-26
 61.6000    56,892   Nov-27
      1,647,885    
SUMMARY OF WARRANT ACTIVITY

A summary of the warrant activity for six months ended June 30, 2026 is as follows:

 

   Shares  

Weighted-Average

Exercise Price

  

Weighted-Average

Remaining

Contractual Term

  

Aggregate

Intrinsic Value

 
Outstanding at January 1, 2026   1,735,869   $           6.94    2.8   $1,415 
Issued   -    -    -      
Forfeited/expired   -    -    -    - 
Exercised   (87,984)   0.95    -    - 
Outstanding at June 30, 2026   1,647,885   $7.26    2.3   $7 
                     
Vested and expected to vest at June 30, 2026   1,647,885   $7.26    2.3   $7 
Exercisable at June 30, 2026   1,647,885   $7.26    2.3   $7 
SCHEDULE OF RESTRICTED STOCK UNITS GRANTS
Grant Date  Recipient  RSUs Granted   Vesting Terms  GDFV1 
1/1/2026  Third-party consultant   250,000   25,000 immediately; remainder monthly over 36 months  $758 
1/8/2026  Interim Executive Chairman   100,000   4 equal quarterly installments over 1 year   321 
1/8/2026  Chief Executive Officer   1,000,000   100,000 on May 15, 2026; 900,000 in 16 quarterly installments over 4 years   3,210 
1/27/2026  Third-party consultant   125,000   16 quarterly installments over 4 years   456 
3/3/2026  Third-party consultant   425,000   212,500 immediately; 125,000 on Jun 3, 2026; 87,500 on Sep 3, 2026   876 
3/16/2026  Third-party consultant   65,000   5,000 immediately; remainder monthly over 1 year   119 
3/16/2026  Chief Financial Officer   500,000   16 quarterly installments over 4 years commencing April 1, 2026   915 
4/27/2026  Employee   175,000   16 quarterly installments over 4 years commencing July 1, 2026   174 
4/27/2026  Third-party consultant   100,000   4 equal quarterly installments over 1 year commencing July 1, 2026   100 
4/27/2026  Third-party consultant   100,000   50,000 immediately; 25,000 on Oct 27, 2026; 25,000 on Apr 27, 2027   100 
4/28/2026  Chief Investment Officer   2,250,000   1,250,000 in 16 quarterly installments over 4 years; 1,000,000 in specified tranches (Apr 2026–Nov 2026)   2,012 
5/25/2026  Employee   500,000   125,000 immediately; 375,000 equally over 8 quarters (Oct 2026–Jul 2028)   640 
       5,590,000      $9,680 

 

  (1) Grant-date fair value (“GDFV”)
SCHEDULE OF ESTIMATED GRANT DATE FAIR VALUE

Assumption  Value 
Grant-date stock price  $2.06 – $3.58 
Stock price milestones  $5.00 – $15.00 
Expected volatility   152.9% – 153.7%
Risk-free interest rate   3.72% – 3.83%
Expected dividend yield   0.00%
Derived service periods (range)   3.43 – 8.84 years 
SCHEDULE OF RELATED TO WARRANTS

The following table presents information related to warrants (ViralClear) at June 30, 2026:

 

Exercise   Number   Expiration
Price   Outstanding   Date
$5.00    473,772   November 2027
SCHEDULE OF OUTSTANDING TO WARRANTS

The following table summarizes information with respect to outstanding warrants to purchase common stock of BioSig AI at June 30, 2026:

 

Exercise   Number   Expiration
Price   Outstanding   Date
$1.00    130,500   June-July 2028
Warrant [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
SUMMARY OF WARRANT ACTIVITY

A summary of the warrant activity for six months ended June 30, 2026 is as follows:

 

           Weighted-Average 
       Weighted-Average   Remaining 
   Shares   Exercise Price   Contractual Term 
Outstanding at January 1, 2026        473,772   $     5.00    1.9 
Forfeited/expired   -    -    - 
Outstanding at June 30, 2026   473,772   $5.00    1.4 
Exercisable at June 30, 2026   473,772   $5.00    1.4 
Viral Clear Pharmaceuticals Inc [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
SCHEDULE OF RESTRICTED STOCK ACTIVITY

The following table summarizes the restricted stock activity for the six months ended June 30, 2026:

 

   Number of Shares  

Weighted-Average Grant Date

Fair Value Per Share

 
Restricted shares issued as of January 1, 2026   2,037,500   $5.36 
Granted   12,152,741   $2.39 
Vested and issued   (7,902,471)  $3.13 
Forfeited   (398,500)  $3.40 
Total   5,889,270   $2.37 
Comprised of:          
Vested restricted shares as of June 30, 2026   -   $- 
Unvested restricted shares as of June 30, 2026   5,889,270   $2.37 
Viral Clear [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
SCHEDULE OF NON VESTED RESTRICTED ACTIVITY

The following table summarizes the restricted stock activity for the six months ended June 30, 2026:

 

 

Restricted shares outstanding at January 1, 2026:   678,679 
Forfeited   - 
Total restricted shares outstanding at June 30, 2026:   678,679 
      
Comprised of:     
Vested restricted shares as of June 30, 2026   678,679 
Unvested restricted shares as of June 30, 2026   - 
Total   678,679 
Equity Option [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
SCHEDULE OF STOCK OPTION ACTIVITY

A summary of the stock option activity and related information for the Plan for the six months ended June 30, 2026 is as follows:

 

   Shares   Weighted-Average Exercise Price   Weighted-Average Remaining Contractual Term   Aggregate Intrinsic Value 
Outstanding at January 1, 2026   2,736,000   $0.78    8.7   $6,745 
Issued   250,000   $3.21    9.5    - 
Forfeited/expired   (65,000)  $5.01           
Outstanding at June 30, 2026   2,921,000   $0.89    8.4   $968 
Exercisable at June 30, 2026   2,921,000   $0.89    8.4   $968 
Performance Shares [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
SCHEDULE OF NON VESTED RESTRICTED ACTIVITY

The following table summarizes PSU activity for the six months ended June 30, 2026:

 

  

PSUs -

Stock Price

  

PSUs -

AUM

  

PSUs -

GLDY Sales

  

Total

PSUs

 
Nonvested as of December 31, 2025   -    -    -    - 
Granted   900,000    1,000,000    3,000,000    4,900,000 
Vested and issued   -    -    -    - 
Canceled / forfeited   (500,000)   -    -    (500,000)
Nonvested as of June 30, 2026   400,000    1,000,000    3,000,000    4,400,000